These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage. Luna M; Kamariski M; Principi I; Bocanegra V; Vallés PG Pediatr Nephrol; 2021 Jun; 36(6):1499-1509. PubMed ID: 33205220 [TBL] [Abstract][Full Text] [Related]
3. Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial). Freedman SB; Schnadower D; Estes M; Casper TC; Goldstein SL; Grisaru S; Pavia AT; Wilfond BS; Metheney M; Kimball K; Tarr PI; Trials; 2023 May; 24(1):359. PubMed ID: 37245030 [TBL] [Abstract][Full Text] [Related]
4. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS). Khalid M; Andreoli S Pediatr Nephrol; 2019 Dec; 34(12):2495-2507. PubMed ID: 30382336 [TBL] [Abstract][Full Text] [Related]
5. Diarrhoea-associated haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infections in New Zealand children: Clinical features and short-term complications from a 23-year cohort study. Wong W; Prestidge C; Dickens A; Ronaldson J J Paediatr Child Health; 2023 Mar; 59(3):493-498. PubMed ID: 36655863 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Treatment for Shiga Toxin-Producing Liu Y; Thaker H; Wang C; Xu Z; Dong M Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668830 [TBL] [Abstract][Full Text] [Related]
7. Outcome 10 years after Shiga toxin-producing E. coli (STEC)-associated hemolytic uremic syndrome: importance of long-term follow-up. Rosales A; Kuppelwieser S; Giner T; Hofer J; Riedl Khursigara M; Orth-Höller D; Borena W; Cortina G; Jungraithmayr T; Würzner R; Pediatr Nephrol; 2024 Aug; 39(8):2459-2465. PubMed ID: 38589699 [TBL] [Abstract][Full Text] [Related]
8. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008. Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224 [TBL] [Abstract][Full Text] [Related]
9. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases. Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort. Monet-Didailler C; Godron-Dubrasquet A; Madden I; Delmas Y; Llanas B; Harambat J Pediatr Nephrol; 2019 Apr; 34(4):657-662. PubMed ID: 30368614 [TBL] [Abstract][Full Text] [Related]
18. Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab. Ağbaş A; Göknar N; Akıncı N; Yıldırım ZY; Taşdemir M; Benzer M; Gökçe İ; Candan C; Küçük N; Uzuner S; Özçelik G; Demirkol D; Sever L; Çalışkan S Pediatr Nephrol; 2018 Dec; 33(12):2371-2381. PubMed ID: 30159625 [TBL] [Abstract][Full Text] [Related]
19. Prodromal Phase of Hemolytic Uremic Syndrome Related to Shiga Toxin-Producing Escherichia coli: The Wasted Time. Balestracci A; Meni Battaglia L; Toledo I; Martin SM; Alvarado C Pediatr Emerg Care; 2021 Oct; 37(10):e625-e630. PubMed ID: 31290797 [TBL] [Abstract][Full Text] [Related]